Probiotics (Multi-Strain, High CFU)Probiotics (multi-strain, high CFU)
Probiotics are live microorganisms that provide a benefit when consumed in adequate amounts, mainly strains from the Lactobacillus and Bifidobacterium groups. Multi-strain products combine several strains, and their content is expressed in CFU (colony-forming units).
Ingested beneficial bacteria produce organic acids such as lactic and acetic acid and short-chain fatty acids in the gut, lowering intestinal pH and creating an environment in which unwanted bacteria find it harder to settle. Short-chain fatty acids are an energy source for intestinal epithelial cells and are known to help maintain the intestinal mucosal barrier (tight junctions) and gut motility. They can also interact with gut-associated lymphoid tissue (GALT), influencing immune signals such as secretory IgA and cytokine balance. Effects vary with strain, dose and duration of intake, and differ widely between individuals.
- A Cochrane systematic review (2022, 23 RCTs, 6,950 participants) reported that, versus placebo, probiotic groups had a lower proportion of people experiencing at least one episode of acute upper respiratory symptoms (RR 0.76) and a shorter average episode duration (about 1.2 days shorter) (low to moderate certainty of evidence).
- A meta-analysis of 20 RCTs in healthy children and adults (2014) reported that groups taking Lactobacillus and Bifidobacterium had fewer days with respiratory symptoms and shorter episodes (by about 0.77 days) than placebo, as well as fewer days absent from school or work.
- A meta-analysis of 15 RCTs in adults with irregular bowel movements (2020) found that probiotics shortened whole-gut transit time by an average of about 13.8 hours and increased weekly bowel movements by about one, with improvements in stool consistency and bloating reported particularly for multi-strain products of two or more strains.
- meta-analysisZhao Y et al. Probiotics for preventing acute upper respiratory tract infections Cochrane Database Syst Rev. 2022. PMID 36001877
- meta-analysisKing S et al. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis Br J Nutr. 2014. PMID 24780623
- meta-analysisZhang C et al. Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adults Clin Nutr. 2020. PMID 32005532




